Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AFFIMED N.V.

(AFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société AFFIMED N.V.
09/08AFFIMED N : UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (Form ..
PU
09/08Affimed Reports Second Quarter 2021 Financial Results and Highlights Operatio..
GL
09/07AFFIMED N : 2021 Virtual Wells Fargo Healthcare Conference
PU
09/06AFFIMED N : Second Quarter 2021 Financial Results and Corporate Update Conferenc..
PU
08/26AFFIMED N : to Present at Upcoming Investor Conferences
AQ
08/23AFFIMED N : to Report Second Quarter 2021 Financial Results & Corporate Update o..
AQ
08/02AFFIMED N : Announces Publication of Comprehensive Preclinical Data Demonstratin..
AQ
07/30AFFIMED N : Announces Publication of Comprehensive Preclinical Data Demonstratin..
AQ
07/01AFFIMED N : Unaudited consolidated statements of comprehensive income / (loss) (..
PU
07/01AFFIMED N : Reports First Quarter 2021 Financial Results and Highlights Operatio..
PU
07/01Affimed Reports First Quarter 2021 Financial Results and Highlights Operation..
GL
06/22Affimed to Report First Quarter 2021 Financial Results & Corporate Update Jul..
GL
06/16AFFIMED N : Annual General Meeting Results (Form 6-K)
PU
06/16Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board
GL
06/13AFFIMED N : 2021 Annual General Meeting
PU
05/31AFFIMED N : Jefferies Virtual Healthcare Conference
PU
05/26Affimed to Present at the Jefferies Virtual Healthcare Conference 2021
GL
05/20Affimed Announces Virtual Annual General Meeting of Shareholders
GL
05/13Affimed Announces Publication of Preclinical Data in Clinical Cancer Research..
GL
04/21AFFIMED N : Amendment to Annual Report by Foreign Issuer (SEC Filing - 20-F/A)
PU
04/16XOMA : Royalty Portfolio Grows with Addition of Three Royalty Assets
AQ
04/15Affimed Reports 2020 Financial Results and Highlights Recent Operational Pro..
GL
04/13AFFIMED N : Fourth Quarter 2020 Financial Results and Corporate Update Conferenc..
PU
04/13CONFERENCE CALL : AACR, data presented on cbNK cells pre-complexed with AFM13
PU
04/12Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-tar..
GL
04/09AFFIMED N : to Report Full Year 2020 Financial Results & Corporate Update on Apr..
AQ
04/09Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1..
GL
04/08Affimed to Report Full Year 2020 Financial Results & Corporate Update on Apr..
GL
04/01AFFIMED N : and NKMax America Announce FDA Clearance of IND Application to Study..
AQ
03/31Affimed and NKMax America Announce FDA Clearance of IND Application to Study ..
GL
03/10Affimed Announces Presentations at the AACR Annual Meeting 2021
GL
03/10Affimed Announces Continuation of REDIRECT, a Registration-directed Study of ..
GL
03/09AFFIMED N : REDIRECT Interim Analysis Webcast
PU
02/03Affimed Announces Collaboration with Roche to Study AFM24 in Combination with..
GL
01/15Affimed Announces Closing of Public Offering of Common Shares and Full Exerci..
GL
01/13Affimed Announces Pricing of $100,000,000 Public Offering of Common Shares
GL
01/12Affimed Announces Proposed Public Offering of Common Shares
GL
01/11Affimed to Present at the 39th Annual J.P. Morgan Healthcare Conference
GL
01/11Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Ba..
GL
01/07Affimed Announces Pipeline and Business Update
GL
2020AFFIMED N : Announces Updated AFM13 Clinical Data Presentation at the American S..
PU
2020Affimed Announces Updated AFM13 Clinical Data Presentation at the American So..
GL
2020Affimed Announces Publication of Final Study Results of its Innate Cell Engag..
GL
2020AFFIMED N : Jefferies Virtual London Healthcare Conference
PU
2020Affimed Reports Third Quarter 2020 Financial Results and Highlights Recent Op..
GL
2020Affimed and Roivant Sciences Announce Licensing and Strategic Collaboration A..
GL
2020New Preclinical Data being Presented at SITC Underscore Promising Combination..
GL
2020AFFIMED N : Third Quarter 2020 Financial Results and Corporate Update Conference..
PU
2020Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collabor..
GL
2020Affimed Announces Presentations on its AFM13 Innate Cell Engager at the 62nd ..
GL
2020Affimed to Present at Upcoming Investor Conferences
GL
2020Affimed to Report 3rd Quarter 2020 Financial Results & Corporate Update Novem..
GL
2020Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted..
GL
2020Affimed Announces Presentation of Preclinical Data on AFM13-targeted NK cells..
GL
2020AbCheck s.r.o. Receives Grant to Further Develop a Discovery Technology for F..
GL
2020Affimed Announces Dosing of First Patient in Phase 1 Clinical Trial of Cord B..
GL
2020Affimed to Present at Jefferies Virtual Cell Therapy Summit
GL
2020AFFIMED N : Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
PU
2020AFFIMED N : 2020 Wells Fargo Virtual Healthcare Conference
PU
2020AFFIMED N : Cantor Virtual Global Healthcare Conference
PU
2020Affimed to Present at Upcoming Investor Conferences
GL
2020Affimed Reports Second Quarter 2020 Financial Results and Operational Progre..
GL
2020Affimed Announces Two New Appointments to Its Supervisory Board
GL
2020Affimed to Report Second Quarter 2020 Financial Results & Corporate Update Au..
GL
2020Affimed Announces Annual General Meeting of Shareholders
GL
2020Affimed Reports First Quarter 2020 Financial Results and Operational Progress
GL
2020Affimed Announces Presentation of Data on Genentech's RO7297089 and AFM24, Bo..
GL
2020Affimed Announces Successful Completion of First Dose Cohort in First-in-Huma..
GL
2020Affimed to Report First Quarter 2020 Financial Results & Corporate Update Jun..
GL
2020Affimed Announces Appointment of Angus Smith as Chief Financial Officer
GL
2020Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 ..
GL
2020Affimed to Present at the Jefferies Virtual Healthcare Conference
GL
2020Affimed Announces Abstracts on Innate Cell Engagers from its ROCK® Platform A..
GL
2020Affimed Reports 2019 Financial Results and Recent Operational Progress
GL
2020Affimed Announces First Patient Successfully Dosed in First-in-Human Phase 1/..
GL
1  2  3  4Next
Upcoming event on AFFIMED N.V.